ALB and hepatocellular carcinoma: The albumin–bilirubin (ALBI) score, initially developed to quantify liver dysfunction in hepatocellular carcinoma, incorporates two routine laboratory markers—albumin and total bilirubin—and reflects both synthetic and metabolic liver function [7,8].